All In Biotech

Drug Trial Radar · NCT00586625

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Last checked: Nov 20, 2026Latest source record: Feb 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 861 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

861

Actual

Start

Oct 2007

Primary completion

May 2008

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Jan 4, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 3 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Safety study for bepotastine besilate ophthalmic solution in normal volunteers

Conditions

  • Allergic Conjunctivitis

Interventions

  • BepreveDrug

    One drop, both eyes, twice a day

  • PlaceboDrug

    One drop, both eyes, twice a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular ComfortTime frame: Day 8 & Day 22

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.